comparemela.com

Protagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Massachusetts ,United States ,Steigen ,Baden Wüberg ,Germany ,Robertb Stein , ,Exchange Commission ,Protagenic Therapeutics Inc ,Department Of Psychiatry At Massachusetts ,Protagenic Therapeutics Inc View ,Dean For Clinical Translational Research ,Nasdaq ,Protagenic Therapeutics ,Trial Focus ,Treatment Resistant Depression ,Generalized Anxiety ,Axiom Real Time Metrics ,Data Analytics ,Maurizio Fava ,Massachusetts General Hospital ,Associate Dean ,Translational Research ,Slater Family Professor ,Harvard Medical School ,Chief Medical Officer ,Looking Statementsthis ,Protagenic Therapeutic ,Risk Factors ,Annual Report ,Financial Officer Protagenic Therapeutics ,Inc View ,

comparemela.com © 2020. All Rights Reserved.